New concepts for the treatment of pediatric nonrhabdomyosarcoma soft tissue sarcomas

References

• Miser JS, Pappo AS, Triche TJ et al. Other soft tissue sarcomas of childhood. In: Principles and Practice of Pediatric Oncology. Pizzo PA, Poplack DG (Eds), Lippincott Williams & Wilkins, PA, USA, 1017–1050 (2002).
   Google Scholar
• Raney B, Parham D, Sommelet-Olive D et al. Summary of the International Symposium on cHildhood Non-rhabdomyosarcoma Soft-tissue Sarcomas, Padua, Italy, February 10–12, 1994. Med. Pediatr. Oncol. 26, 425–430 (1996).
   Google Scholar
• Paulino AC. Treatment options for children with nonrhabdomyosarcoma soft tissue sarcoma. Expert Rev. Anticancer Ther. 4, 247–256 (2004).
   PubMedGoogle Scholar
• Gronchi A, Casali PG, Mariani L et al. Status of surgical margins and prognosis in adult soft tissue sarcomas of the extremities: a series of 911 consecutive patients treated at a single institution. J. Clin. Oncol. 23(1), 96–104 (2005).
   PubMed Web of Science ®Google Scholar
• Hays DM, Lawrence W Jr, Wharam M et al. Primary re-excision for patients with ‘microscopic residual’ tumor following initial excision of sarcomas of trunk and extremity sites. J. Pediatr. Surg. 24, 5–10 (1989).
   PubMed Web of Science ®Google Scholar
• Cecchetto G, Guglielmi M, Inserra A et al. Primary re-excision: the Italian experience in patients with localized soft-tissue sarcomas. Pediatr. Surg. Int. 17, 532–534 (2001).
   PubMed Web of Science ®Google Scholar
• Enneking WF. Staging of musculoskeletal neoplasms. In Current Concepts of Diagnosis and Treatment of Bone and Soft Tissue Tumors. Uhtoff H (Ed.), Springer-Verlag, Heidelberg, Germany (1984).
   Google Scholar
• Stojadinovic A, Leung DHY, Hoos A et al. Analysis of the prognostic significance of microscopic margins in 2084 localized primary adult soft tissue sarcomas. Ann. Surg. 235, 424–443 (2002).
   PubMed Web of Science ®Google Scholar
• Zagars GK, Ballo MT, Pisters PWT et al. Prognostic factors for patients with localized soft tissue sarcoma treated with conservation surgery and radiation therapy. An analysis of 1225 patients. Cancer 97, 2530–2543 (2003).
   PubMed Web of Science ®Google Scholar
• Eilber FC, Rosen G, Nelson SD et al. High grade extremity soft tissue sarcomas. Factor predictive of local recurrence and its effect on morbidity and mortality. Ann. Surg. 237, 218–226 (2003).
   PubMed Web of Science ®Google Scholar
• Lewis JJ, Leung DHY, Heslin M et al. Association of local recurrence with subsequent survival in extremity soft tissue sarcoma. J. Clin. Oncol. 15, 646–652 (1997).
   PubMed Web of Science ®Google Scholar
• Rao BN. Nonrhabdomyosarcoma in children: prognostic factors influencing survival. Semin. Surg. Oncol. 9, 524–531 (1993).
   PubMedGoogle Scholar
• Hayes-Jordan AA, Spunt SL, Poquette CA et al. Nonrhabdomyosarcoma soft tissue sarcomas in children: is age at diagnosis an important variable? J. Pediatr. Surg. 35, 948–954 (2000).
   PubMed Web of Science ®Google Scholar
• Kattan MW, Leung DHY, Brennan MF. Postoperative normogram for 12-year sarcoma-specific death. J. Clin. Oncol. 20, 791–796 (2002).
   PubMed Web of Science ®Google Scholar
• Pisters PW, Leung DH, Woodruff J et al. Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J. Clin. Oncol. 14, 1679–1689 (1996).
   PubMed Web of Science ®Google Scholar
• Koea JB, Leung D, Lewis JJ et al. Histopathologic type: an independent prognostic factor in primary soft tissue sarcoma of the extremity? Ann. Surg. Oncol. 10, 432–440 (2003).
   PubMed Web of Science ®Google Scholar
• Coindre JM, Terrie P, Bui NB et al. Prognostic factors in adult patients with locally controlled soft tissue sarcoma: a study of 546 patients from the French Federation of Cancer Centers Sarcoma Group. J. Clin. Oncol. 14, 869–877 (1996).
   PubMed Web of Science ®Google Scholar
• Coindre JM, Terrier P, Guillou L et al. Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas: a study of 1240 patients from the French Federation of Cancer Centers Sarcoma Group. Cancer 91, 1914–1926 (2001).
   PubMed Web of Science ®Google Scholar
• Pratt CB, Pappo AS, Gieser P et al. Role of adjuvant chemotherapy in the treatment of surgically resected pediatric nonrhabdomyosarcomatous soft tissue sarcomas: a Pediatric Oncology Group Study. J. Clin. Oncol. 17, 1219–1226 (1999).
   PubMed Web of Science ®Google Scholar
• Marcus KC, Grier HE, Shamberger RC et al. Childhood soft tissue sarcoma: a 20-year experience. J. Pediatr. 131, 603–607 (1997).
   PubMed Web of Science ®Google Scholar
• McGrory JE, Pritchard DJ, Arndt CA et al. Nonrhabdomyosarcoma soft tissue sarcomas in children: the Mayo Clinic experience. Clin. Orthop. 374, 247–258 (2000).
   Google Scholar
• Spunt SL, Poquette CA, Hurt YS et al. Prognostic factors for children and adolscents with surgically resected nonrhabdomyosarcoma soft tissue sarcoma: an analysis of 121 patients treated at St Jude Children’s Research Hospital. J. Clin. Oncol. 17, 3697–3705 (1999).
   PubMed Web of Science ®Google Scholar
• Spunt SL, Ashley Hill D, Motosue AM et al. Clinical features and outcome of initially unresected nonmetastatic pediatric nonrhaddomyosarcoma soft tissue sarcoma. J. Clin. Oncol. 20, 3225–3235 (2002).
   PubMed Web of Science ®Google Scholar
• Walter AW, Shearer PD, Pappo AS et al. A pilot study of vincristine, ifosfamide, and doxorubicin in the treatment of pediatric non-rhabdomyosarcoma soft tissue sarcomas. Med. Pediatr. Oncol. 30, 210–216 (1998).
   PubMedGoogle Scholar
• Pratt CB, Maurer HM, Gieser P et al. Treatment of unresectable or metastatic pediatric soft tissue sarcomas with surgery, irradiation, and chemotherapy: a Pediatric Oncology Group Study. Med. Pediatr. Oncol. 30, 201–209 (1998).
   PubMedGoogle Scholar
• Ferrari A, Casanova M, Meazza C et al. Adult-type soft tissue sarcomas in pediatric age: experience at the Istituto Nazionale Tumori in Milan. J. Clin. Oncol. (2005) (In Press).
   Google Scholar
• Ladenstein R, Treuner J, Koscielniak E et al. Synovial sarcoma of childhood and adolescence: report of the German CWS-81 study. Cancer 71, 3647–3655 (1993).
   PubMed Web of Science ®Google Scholar
• Ferrari A, Casanova M, Massimino M et al. Synovial sarcoma: report of a series of 25 consecutive children from a single institution. Med. Pediatr. Oncol. 32, 32–37 (1999).
   PubMedGoogle Scholar
• Weitz J, Antonescu CR, Brennan MF. Localized extremity soft tissue sarcoma: improved knowledge with unchanged survival over time. J. Clin. Oncol. 21, 2719–2725 (2003).
   PubMed Web of Science ®Google Scholar
• Edmonson JH, Ryan LM, Blum RH et al. Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas. J. Clin. Oncol. 11, 1269–1275 (1993).
   PubMed Web of Science ®Google Scholar
• Bramwell V, Rouesse J, Steward W et al. Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma – reduced local recurrence but no improvement in survival: a study on the European Organization for Research and Treatment of Cancer Soft Tissue Sarcoma and Bone Sarcoma Group. J. Clin. Oncol. 12, 1137–1149 (1994).
   PubMed Web of Science ®Google Scholar
• Antman K, Crowley J, Balcerzak SP et al. An intergroup Phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas. J. Clin. Oncol. 11, 1276–1285 (1993).
   PubMed Web of Science ®Google Scholar
• Patel SR, Vadhan-Raj S, Papadopolous N et al. High-dose ifosfamide in bone and soft tissue sarcomas: results of Phase II and pilot studies – dose-response and schedule dependence. J. Clin. Oncol. 15, 2378–2384 (1997).
   PubMed Web of Science ®Google Scholar
• Rosen G, Forscher C, Lowenbraun S et al. Synovial sarcoma: uniform response of metastases to high dose ifosfamide. Cancer 73, 2506–2511 (1994).
   PubMed Web of Science ®Google Scholar
• Pappo AS, Fontanesi J, Luo X et al. Synovial sarcoma in children and adolescents: the St. Jude Children’s Research Hospital experience. J. Clin. Oncol. 12, 2360–2366 (1994).
   PubMed Web of Science ®Google Scholar
• Okcu MF, Munsell M, Treuner J et al. Synovial sarcoma of childhood and adolescence: a multicenter, multivariate analysis of outcome. J. Clin. Oncol. 21, 1602–1611 (2003).
   PubMed Web of Science ®Google Scholar
• Ferrari A, Gronchi A, Casanova M et al. Synovial sarcoma: a retrospective analysis of 271 patients of all ages treated at a single institution. Cancer 101, 627–634 (2004).
   PubMed Web of Science ®Google Scholar
• Brodsky JT, Burt ME, Hajdu SI et al. Tendosynovial sarcoma: clincopathologic features, treatment and prognosis. Cancer 70, 484–489 (1992).
   PubMed Web of Science ®Google Scholar
• Bergh P, Meis-Kindblom JM, Gherlinzoni F et al. Synovial sarcoma: identification of low and high risk groups. Cancer 85, 2596–2607 (1999).
   PubMed Web of Science ®Google Scholar
• Lewis JJ, Antonescu CR, Leung DHY et al. Synovial sarcoma: a multivariate analysis of prognostic factors in 112 patients with primary localized tumors of the extremity. J. Clin. Oncol. 18, 2087–2094 (2000).
   PubMed Web of Science ®Google Scholar
• Spillane AJ, A’Hern R, Judson IR et al. Synovial sarcoma: a clinicopathologic, staging, and prognostic assessment. J. Clin. Oncol. 18, 3794–3803 (2000).
   PubMed Web of Science ®Google Scholar
• Trassard M, Le Doussal V, Hacène K et al. Prognostic factors in localized primary synovial sarcoma: a multicenter study of 128 adult patients. J. Clin. Oncol. 19, 525–534 (2001).
   PubMed Web of Science ®Google Scholar
• Sarcoma Meta-analysis Collaboration. Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Lancet 350, 1647–1654 (1997).
   PubMed Web of Science ®Google Scholar
• Frustaci S, Gherlinzoni F, De Paoli A et al. Adjuvant chemotherapy for adult soft tissue sarcomas of extremities and girdles: results of the Italian randomized co-operative trial. J. Clin. Oncol. 19, 1238–1247 (2001).
   PubMed Web of Science ®Google Scholar
• Yang JC, Chang AE, Baker AR et al. Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J. Clin. Oncol. 16, 197–203 (1998).
   PubMed Web of Science ®Google Scholar
• DeLaney TF, Spiro IJ, Suit HD et al. Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas. Int. J. Radiat. Oncol. Biol. Phys. 56, 1117–1127 (2003).
   PubMed Web of Science ®Google Scholar
• O’Sullivan B, Davis AM, Turcotte R et al. Preoperative versus postoperative radiotherapy in soft tissue sarcoma of the limbs: a randomized trial. Lancet 359, 2235–2241 (2002).
   PubMed Web of Science ®Google Scholar
• Khanfir K, Alzieu L, Terrier P et al. Does adjuvant radiation therapy increase loco-regional control after optimal resection of soft-tissue sarcoma of the extremity? Eur. J. Cancer 39, 1872–1880 (2003).
   PubMed Web of Science ®Google Scholar
• Baldini EH, Goldberg J, Jenner C et al. Long-term outcomes after function-sparing surgery without radiotherapy for soft tissue sarcoma of the extremity and trunk. J. Clin. Oncol. 17, 3252–3259 (1999).
   PubMed Web of Science ®Google Scholar
• Cormier JN, Langstein HN, Pisters PW. Preoperative therapy for soft tissue sarcoma. Cancer Treat. Res. 120, 43–63 (2004).
   PubMedGoogle Scholar
• Ward I, Haycocks T, Sharpe M et al. Volume-based radiotherapy targeting in soft tissue sarcoma. Cancer Treat. Res. 120, 17–42 (2004).
   PubMedGoogle Scholar
• Oberlin O, Rey A, Anderson J et al. Treatment of orbital rhabdomyosarcoma: survival and late effects of treatment – results of an international workshop. J. Clin. Oncol. 19, 197–204 (2001).
   PubMed Web of Science ®Google Scholar
• Trojani M, Contesso G, Coindre JM et al. Soft tissue sarcomas of adults: study of pathological prognostic variables and definitions of a histopathological grading system. Int. J. Cancer 33, 37–42 (1984).
   PubMed Web of Science ®Google Scholar
• Parham DM, Webber BL, Jenkins JJ et al. Nonrhabdomyosarcomatous soft tissue sarcomas of childhood: formulation of a simplified system for grading. Mod. Pathol. 8, 705–710 (1995).
   PubMed Web of Science ®Google Scholar
• Guillou L, Coindre JM, Bonichon F et al. Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adults patients with soft tissue sarcoma. J. Clin. Oncol. 15, 350–362 (1997).
   PubMed Web of Science ®Google Scholar
• Bramwell VHC. Adjuvant chemotherapy for adult soft tissue sarcoma: is there a standard of care? J. Clin. Oncol. 19, 1235–1237 (2001).
   PubMed Web of Science ®Google Scholar
• Demetri GD. Highlights of sarcoma research. J. Clin. Oncol. Classic Papers Curr. Comments 7, 681–684 (2002).
   Google Scholar
• Ferrari A, Brecht IB, Koscielniak E et al. Could adjuvant chemotherapy have a role in surgically-resected adult-type soft tissue sarcomas of children and adolescents. Pediatr. Blood Cancer (2005) (In Press).
   Google Scholar
• Alvegard TA, Sigurdsson H, Mouridsen H et al. Adjuvant chemotherapy with doxorubicin in high grade soft tissue sarcoma: a randomized trial of the Scandinavian Sarcoma Group. J. Clin. Oncol. 7, 1504–1513 (1989).
   PubMed Web of Science ®Google Scholar
• Santoro A, Tursz T, Mouridsen H et al. Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. J. Clin. Oncol. 13, 1537–1545 (1995).
   PubMed Web of Science ®Google Scholar
• Cormier JN, Huang X, Xing Y et al. Cohort analysis of patients with localized, high-risk, extremity soft tissue sarcoma treated at two cancer centers: chemotherapy-associated outcomes. J. Clin. Oncol. 22, 4567–4574 (2004).
   PubMed Web of Science ®Google Scholar
• Cecchetto G, Carli M, Alaggio R et al. Fibrosarcoma in pediatric patients: results of the Italian Co-operative Group studies (1979–1995). J. Surg. Oncol. 78, 225–231 (2001).
   PubMed Web of Science ®Google Scholar
• Shetty AK, Yu LC, Gardner RV, Warrier RP. Role of chemotherapy in the treatment of infantile fibrosarcoma. Med. Pediatr. Oncol. 33, 425–427 (1999).
   PubMedGoogle Scholar
• Loh ML, Ahn P, Perez-Atayde AR et al. Treatment of infantile fibrosarcoma with chemotherapy and surgery: results from the Dana–Farber Cancer Institute and Children’s Hospital, Boston. Pediatr. Hematol. Oncol. 24, 722–726 (2002).
   Web of Science ®Google Scholar
• Gururangan S, Bowman LC, Parham DM et al. Primary extracranial rhabdoid tumors. Cancer 71, 2653–2659 (1993).
   PubMed Web of Science ®Google Scholar
• Biegel JA, Zhou J-Y, Rorke LB et al. Germ-line and acquired mutations of INII in atypical teratoid and rhabdoid tumors. Cancer Res. 59, 74–79 (1999).
   PubMed Web of Science ®Google Scholar
• Kodet R, Newton WA Jr, Sachs N et al. Rhabdoid tumors of soft tissues: a clinicopathologic study of 26 cases enrolled on the Intergroup Rhabdomyosarcoma Study. Hum. Pathol. 22, 674–684 (1991).
   PubMed Web of Science ®Google Scholar
• Brennan BMD, Foot AB, Stiller C et al. Where to next with extracranial rhabdoid tumors in children. Eur. J. Cancer 40, 624–626 (2004).
   PubMed Web of Science ®Google Scholar
• Bisogno G, Roganovich J, Sotti G et al. Desmoplastic small round cell tumor in children and adolescents. Med. Ped. Oncol. 34, 338–342 (2000).
   PubMedGoogle Scholar
• Kushner BH, La Quaglia MP, Wollner N et al. Desmoplastic small round-cell tumor: prolonged progression-free survival with aggressive multimodality therapy. J. Clin. Oncol. 14, 1526–1531 (1996).
   PubMed Web of Science ®Google Scholar
• Bollinger BK, Laskin WB, Knight CB. Epithelioid hemangioendothelioma with multiple site involvement. Literature review and observations. Cancer 73, 610–615 (1994).
   PubMed Web of Science ®Google Scholar
• Ferrari A, Casanova M, Bisogno G et al. Vascular tumors in pediatric age. The experience of the Italian and German Co-operative Group. Italian J. Pediatr. 27, 774–778 (2001).
   Google Scholar